mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.8 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0099 |
0.8 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.8 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.8 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
-0.0096 |
0.8 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.8 |